Agency Forms Undergoing Paperwork Reduction Act Review, 14252-14253 [2014-05482]
Download as PDF
<![CDATA[
14252
Federal Register / Vol. 79, No. 49 / Thursday, March 13, 2014 / Notices
for agencies requesting authorization to
use the General Purpose and Special
Purpose delegation authority and
established revised reporting
requirements, including the submission
of documents to GSA at various points
in the lease acquisition process, and
required agencies to have in place an
organizational structure to support the
delegation, ensure compliance with all
applicable laws, regulations and GSA
directives governing the lease
acquisition and administer the lease.
FMR Bulletin 2008–B1 also addressed
requirements for another longstanding
delegation for Categorical space, as
provided in 41 CFR part 102–73.
FMR Bulletin C–2 re-emphasizes and
updates the conditions, restrictions and
reporting requirements applicable to
GSA leasing delegations.
Dated: March 10, 2014.
Anne E. Rung,
Associate Administrator.
[FR Doc. 2014–05548 Filed 3–12–14; 8:45 am]
BILLING CODE 6820–14–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30-Day–14–14BB]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call (404) 639–7570 or send an
email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC 20503 or by fax to (202) 395–5806.
Written comments should be received
within 30 days of this notice.
Juan. We will ensure that at least 20%
of participants are black and at least
15% are Hispanic. Recruitment will be
conducted through banner
advertisements displayed on social
networking sites such as Facebook and
dating and sex-seeking sites such as
Manhunt and Adam4Adam.
This study also has a qualitative
component that aims to examine the
experiences of participants in the
randomized control trial. Participants
for the qualitative data collection will be
drawn from the randomized control
trial. Two data collection techniques
will be used: Focus group discussions
(FGD) (both online and in-person) and
individual in-depth interviews (IDIs).
CDC is requesting approval for a 3year clearance for data collection. All
participant consenting and data
collection for the RCT will be completed
using an online reporting system. Data
will be collected using an eligibility
screener, an online study registration
process, a baseline survey, HIV test
results reporting system, and follow-up
surveys. Men will be asked to use the
study Web site or download and access
a secure cell phone application prior to
enter results of their rapid HIV hometests that they receive and conduct at
home and to take the follow-up surveys
which will collect information on HIV
testing results and behaviors and sexual
activities. Focus group discussions and
in-depth interviews will be used to
examine experiences of participants in
the RCT.
The duration of the eligibility
screener is estimated to be 5 minutes;
the RCT consent 10 minutes; the study
registration process 5 minutes; the
baseline survey 15 minutes; the
reporting of home-test results 5 minutes;
the follow-up surveys 10 minutes; the
focus group and individual interview
consents 10 minutes each; the focus
group discussion 1 hour and 30
minutes; and the in-depth interviews 1
hour and 15 minutes.
There is no cost to participants other
than their time. The total estimated
annual burden hours are 7,085.
Proposed Project
Evaluation of Rapid HIV HomeTesting among MSM Trial—New—
National Center for HIV/AIDS, Viral
Hepatitis, STD, TB Prevention
(NCHHSTP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
Innovative testing strategies are
needed to reduce levels of undiagnosed
HIV infection and increase early access
to treatment. Rapid home HIV tests may
play an important role in efforts to
reduce both HIV morbidity and
mortality. Given the unrelenting HIV
crisis among MSM and the release into
the market of a rapid HIV test for athome use, it is necessary to evaluate the
impact of providing rapid HIV hometest kits on repeat HIV testing, linkage
to care, partner testing, serosorting, and
HIV sexual risk behaviors among MSM.
This information will assist the Division
of HIV/AIDS Prevention (DHAP) in
developing recommendations, future
research and program needs concerning
home-testing for MSM.
Specific aims
This study is a randomized trial
which aims to evaluate the use and
effectiveness of home-test kits as a
public health strategy for increasing
testing among MSM. A secondary aim of
the randomized trial is to evaluate the
extent to which MSM (both HIVnegative and HIV-positive) distribute
HIV home-test kits to their social and
sexual networks.
The population for the randomized
trial will be men over the age of 18 years
who self-report that they have had anal
sex with at least one man in the past
year. We will recruit approximately
3,200 men who report their HIV status
to be negative or who are unaware of
their HIV status and 300 men who selfreport that they are HIV-positive. Men
will be recruited from the 12 cities:
Atlanta, Baltimore, Chicago, Dallas, the
District of Columbia, Houston, Los
Angeles, Miami, New York City,
Philadelphia, San Francisco, and San
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
TKELLEY on DSK3SPTVN1PROD with NOTICES
Type of respondent
Form name
Prospective Participant ..........
Enrolled participant ................
Enrolled participant ................
Enrolled participant ................
Enrolled participant ................
Enrolled participant ................
Enrolled participant ................
Enrolled participant ................
Enrolled participants ..............
Eligibility Screener .................................................................
Study Registration .................................................................
Consent for RCT ...................................................................
Baseline Survey for RCT .......................................................
Baseline Survey for HIV-positive group ................................
Reporting of Home-test Results during study .......................
Follow-up Surveys for RCT ...................................................
Follow-up Surveys for HIV positive group .............................
Reporting of Home-test Results at completion of study .......
VerDate Mar<15>2010
17:33 Mar 12, 2014
Jkt 232001
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
24,000
14,000
3,200
3,200
300
1,600
3,200
300
3,200
E:\FR\FM\13MRN1.SGM
13MRN1
1
1
1
1
1
3
4
2
1
Average hours
per response
3/60
5/60
10/60
15/60
15/60
5/60
10/60
10/60
5/60
14253
Federal Register / Vol. 79, No. 49 / Thursday, March 13, 2014 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Type of respondent
Enrolled
Enrolled
Enrolled
Enrolled
participant
participant
participant
participant
................
................
................
................
Focus group consent .............................................................
Focus group discussion .........................................................
Individual in-depth interview guide consent ..........................
Individual in-depth interview guide ........................................
LeRoy Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2014–05482 Filed 3–12–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60-Day–14–0895]
TKELLEY on DSK3SPTVN1PROD with NOTICES
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–7570 or send
comments to LeRoy Richardson, 1600
Clifton Road, MS–D74, Atlanta, GA
30333 or send an email to omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
VerDate Mar<15>2010
17:33 Mar 12, 2014
Number of
respondents
Form name
Jkt 232001
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Community-based Organization
Monitoring and Evaluation of Respect
(OMB No.0920–0895 exp. 8/31/2014)—
Revision—National Center for HIV/
AIDS, Viral Hepatitis, STD, and TB
Prevention, Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
CDC began formally partnering with
Community-based Organizations (CBOs)
in the late 1980s to expand the reach of
HIV prevention efforts. CBOs were, and
continue to be, recognized as important
partners in HIV prevention because of
their history and credibility with target
populations and their access to groups
that may not be easily reached. Over
time, CDC’s program for HIV prevention
by CBOs has grown in size, scope, and
complexity to respond to changes in the
epidemic, including the diffusion and
implementation of Effective Behavioral
Interventions (EBIs) for HIV prevention.
CDC’s EBIs have been shown to be
effective under controlled research
environments, but there is limited data
on intervention implementation and
client outcomes in real-world settings
(as implemented by CDC-funded CBOs).
The purpose of Community-based
Organization Monitoring and Evaluation
of Respect (CMEP-Respect) is to: (a)
Assess the fidelity of the
implementation of the selected
intervention at the CBO; and (b)
improve the performance of CDCfunded CBOs delivering the Respect
intervention by monitoring changes in
clients’ self-reported attitudes and
beliefs regarding HIV and HIV
transmission risk behaviors after
participating in Respect.
CDC funded four (4) CBOs to
participate in CMEP-Respect for five (5)
years (September 2010-August 2015).
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Average hours
per response
1
1
1
1
10/60
1.5
10/60
1.5
216
216
30
30
From September 1, 2012 through
January 31, 2014, baseline surveys were
conducted with 684 participants; 90-day
follow up surveys were completed with
459 participants, and 180-day follow up
surveys were completed with 343
participants.
CDC is requesting additional time to
complete follow up surveys at 90- and
180-days for participants completing the
intervention on or before August 31,
2014. Following their participation in
the Respect intervention, participants
will complete an 18 minute, self
administered, computer based interview
at two follow-up time points (90- and
180-days following the Respect
intervention) to assess their HIV-related
attitudes and behavioral risks. CBOs
will be expected to retain 80% of these
participants at both follow-up time
points.
Throughout the project, funded CBOs
will be responsible for managing the
daily procedures of CMEP-Respect to
ensure that all required activities are
performed, all deadlines are met, and
quality assurance plans, policies and
procedures are upheld. CBOs will be
responsible for participating in all CDCsponsored grantee meetings related to
CMEP-Respect.
Findings from this project will be
primarily used by the participating
CBOs. The CBOs may use the findings
to: (a) Better understand if the outcomes
are different across demographic and
behavioral risk groups as well as agency
and program model characteristics; and
(b) improve the future implementation,
management, and quality of Respect.
CDC and other organizations interested
in behavioral outcome monitoring of
Respect or similar HIV prevention
interventions can also benefit from
lessons learned through this project.
In this request, CDC is requesting
approval for approximately 200 burden
hours. There is no cost to respondents
except for their time.
E:\FR\FM\13MRN1.SGM
13MRN1
]]>Agencies
[Federal Register Volume 79, Number 49 (Thursday, March 13, 2014)]
[Notices]
[Pages 14252-14253]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-05482]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30-Day-14-14BB]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
(404) 639-7570 or send an email to omb@cdc.gov. Send written comments
to CDC Desk Officer, Office of Management and Budget, Washington, DC
20503 or by fax to (202) 395-5806. Written comments should be received
within 30 days of this notice.
Proposed Project
Evaluation of Rapid HIV Home-Testing among MSM Trial--New--National
Center for HIV/AIDS, Viral Hepatitis, STD, TB Prevention (NCHHSTP),
Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Innovative testing strategies are needed to reduce levels of
undiagnosed HIV infection and increase early access to treatment. Rapid
home HIV tests may play an important role in efforts to reduce both HIV
morbidity and mortality. Given the unrelenting HIV crisis among MSM and
the release into the market of a rapid HIV test for at-home use, it is
necessary to evaluate the impact of providing rapid HIV home-test kits
on repeat HIV testing, linkage to care, partner testing, serosorting,
and HIV sexual risk behaviors among MSM. This information will assist
the Division of HIV/AIDS Prevention (DHAP) in developing
recommendations, future research and program needs concerning home-
testing for MSM.
Specific aims
This study is a randomized trial which aims to evaluate the use and
effectiveness of home-test kits as a public health strategy for
increasing testing among MSM. A secondary aim of the randomized trial
is to evaluate the extent to which MSM (both HIV-negative and HIV-
positive) distribute HIV home-test kits to their social and sexual
networks.
The population for the randomized trial will be men over the age of
18 years who self-report that they have had anal sex with at least one
man in the past year. We will recruit approximately 3,200 men who
report their HIV status to be negative or who are unaware of their HIV
status and 300 men who self-report that they are HIV-positive. Men will
be recruited from the 12 cities: Atlanta, Baltimore, Chicago, Dallas,
the District of Columbia, Houston, Los Angeles, Miami, New York City,
Philadelphia, San Francisco, and San Juan. We will ensure that at least
20% of participants are black and at least 15% are Hispanic.
Recruitment will be conducted through banner advertisements displayed
on social networking sites such as Facebook and dating and sex-seeking
sites such as Manhunt and Adam4Adam.
This study also has a qualitative component that aims to examine
the experiences of participants in the randomized control trial.
Participants for the qualitative data collection will be drawn from the
randomized control trial. Two data collection techniques will be used:
Focus group discussions (FGD) (both online and in-person) and
individual in-depth interviews (IDIs).
CDC is requesting approval for a 3-year clearance for data
collection. All participant consenting and data collection for the RCT
will be completed using an online reporting system. Data will be
collected using an eligibility screener, an online study registration
process, a baseline survey, HIV test results reporting system, and
follow-up surveys. Men will be asked to use the study Web site or
download and access a secure cell phone application prior to enter
results of their rapid HIV home-tests that they receive and conduct at
home and to take the follow-up surveys which will collect information
on HIV testing results and behaviors and sexual activities. Focus group
discussions and in-depth interviews will be used to examine experiences
of participants in the RCT.
The duration of the eligibility screener is estimated to be 5
minutes; the RCT consent 10 minutes; the study registration process 5
minutes; the baseline survey 15 minutes; the reporting of home-test
results 5 minutes; the follow-up surveys 10 minutes; the focus group
and individual interview consents 10 minutes each; the focus group
discussion 1 hour and 30 minutes; and the in-depth interviews 1 hour
and 15 minutes.
There is no cost to participants other than their time. The total
estimated annual burden hours are 7,085.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of
Type of respondent Form name Number of responses per Average hours
respondents respondent per response
----------------------------------------------------------------------------------------------------------------
Prospective Participant............ Eligibility Screener...... 24,000 1 3/60
Enrolled participant............... Study Registration........ 14,000 1 5/60
Enrolled participant............... Consent for RCT........... 3,200 1 10/60
Enrolled participant............... Baseline Survey for RCT... 3,200 1 15/60
Enrolled participant............... Baseline Survey for HIV- 300 1 15/60
positive group.
Enrolled participant............... Reporting of Home-test 1,600 3 5/60
Results during study.
Enrolled participant............... Follow-up Surveys for RCT. 3,200 4 10/60
Enrolled participant............... Follow-up Surveys for HIV 300 2 10/60
positive group.
Enrolled participants.............. Reporting of Home-test 3,200 1 5/60
Results at completion of
study.
[[Page 14253]]
Enrolled participant............... Focus group consent....... 216 1 10/60
Enrolled participant............... Focus group discussion.... 216 1 1.5
Enrolled participant............... Individual in-depth 30 1 10/60
interview guide consent.
Enrolled participant............... Individual in-depth 30 1 1.5
interview guide.
----------------------------------------------------------------------------------------------------------------
LeRoy Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2014-05482 Filed 3-12-14; 8:45 am]
BILLING CODE 4163-18-P
